Search Press releases Keywords From To 24 Aug 2021 UCB Announces European Commission Approval of BIMZELX[®]▼ (bimekizumab) for the Treatment of Adults with Moderate to Severe Plaque Psoriasis Read More 20 Aug 2021 Disposals of own shares Read More 13 Aug 2021 Disposals of own shares Read More 9 Aug 2021 Transparency notification FMR LLC. Read More 7 Aug 2021 New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis Read More 6 Aug 2021 Disposals of own shares Read More Pagination First page Previous page Previous … Page 31 Page 32 Page 33 Page 34 Current page 35 Page 36 Page 37 Page 38 Page 39 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
